View full article on the link
The Asia-Pacific Sovereign Seesaw: If Oil Prices Soar, Some Ratings Could Fall
Tensions in the Middle East are likely to keep oil prices elevated in the near future despite recent declines. Most observers don't expect the U.S.-Iran standoff to escalate into conflict. Even so, it has already begun to hurt economically. A widely expected weak year for economic growth now has the potential to worsen. A further large increase in crude oil prices would adversely affect most Asia-Pacific economies. If prices stay above US$150 for more than a year, some sovereigns in the region could be downgraded.
• Novo Nordisk A/S (NVO) to Boost US Workforce by 15 Percent More...
• Imprimis Pharmaceuticals Closes $7.95 Million Financing and Provides Progress Report to Shareholders More...
• Jazz Pharmaceuticals, Inc. (JAZZ) Buying EUSA Pharma for Up to $700 Million More...
• Renhe Pharmacy Pays $46 Million for Two Pharma Acquisitions More...
• Allenex AB Sells Its Holding in Pharmacolog More...
• VWR International, Inc. Signs Agreement to Acquire basan Germany GmbH More...
• FAES Farma and Invida (a Menarini Group Company) Announce Agreement to Commercialize Bilastine in 17 Markets in Asia - Pacific More...
• Somaxon Pharmaceuticals, Inc. (SOMX) and CJ CheilJedang Announce Silenor® Collaboration in South Korea More...
• Array BioPharma, Inc. (ARRY) Names Ron Squarer Chief Executive Officer More...
• Trinean nv Appoints New CEO and Secures 2.7 Million Euro Financing More...
• PDL BioPharma, Inc. (PDLI) Appoints Bruce Tomlinsonas Chief Financial Officer More...
• Ms. Julia R. Brown and Mr. Davey S. Scoon Join Biodel Inc. (BIOD) Board of Directors More...
• Lota S. Zoth Joins Orexigen Therapeutics, Inc. (OREX) Board of Directors More...
• Alnylam Pharmaceuticals (ALNY) to Webcast Conference Call Discussing First Quarter 2012 Financial Results More...
• Accelrys Inc. (ACCL) to Announce First Quarter 2012 Results on May 3, 2012 More...
• First Quarter 2012/Annual Meeting: BASF With Solid Start to the Year More...
• BioMarin Pharmaceutical Inc. (BMRN) Announces First Quarter 2012 Financial Results More...
• BioScrip (BIOS) to Host First Quarter 2012 Earnings Call More...
• Could Bristol-Myers Squibb Company (BMY) be a Target of Bribery? More...
• Sucampo Pharmaceuticals, Inc. Provides Update on Anticipated Arbitration Decision Date More...
• FDA Rejects Amgen (AMGN)'s BLA for Xgeva More...
• GlaxoSmithKline (GSK) and Genmab A/S (GEN.CO) Release: New Drug Application for Arzerra Submitted in Japan More...
• FDA Warns Not to Mix Merck & Co., Inc. (MRK) Hep C Drug With HIV Meds More...
• FDA Approves Novartis AG (NVS)'s Afinitor for Kidney Tumors More...
• FDA Approves GlaxoSmithKline (GSK)'s Votrient® for Deadly Sarcomas More...
• Results From Chelsea Therapeutics, Inc. (CHTP)' Pivotal Northera (Droxidopa) Study to be Presented at the American Academy of Neurology's Annual Meeting More...
• Baxter International, Inc. (BAX) Presents Efficacy and Safety Data Evaluating GAMMAGARD LIQUID for Multifocal Motor Neuropathy at American Academy of Neurology Annual Meeting More...
• UCB, Inc. (UCBJF.PK) Release: Interim results of VITOBA (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology More...
• New Tysabri Data Presented at 64th Annual American Academy of Neurology Meeting Highlight Biogen Idec, Inc. (Massachusetts) (BIIB) & Biogen Idec, Inc. (Massachusetts) (BIIB) Commitment to Improving Outcomes in Multiple Sclerosis More...
• Building Muscle Without Heavy Weights, McMaster University Study More...
• Analytic Thinking Can Decrease Religious Belief, University of British Columbia Study More...
• Women Who Smoke in Pregnancy More Likely to Have Child With High Functioning Autism, University of Wisconsin Study More...
• High Salt Intake Linked to Higher Stroke Risk, University of Warwick Study More...
• Breast Cancer Link With Diet, Karolinska Institute Study More...
• Ampio Pharmaceuticals, Inc. (AMPE) Awarded US and Canadian Patents That Will Bolster the Commercialization of Optina for the Treatment of Diabetic Macular Edema (DME) More...
• Ranbaxy Laboratories (RANBAXY.BO) Creates India's First New Drug More...
• Pharmaxis Ltd (PXS.AX) Receives Approval to Market Bronchitol in the EU More...
• GlaxoSmithKline (GSK) Attacks National Institute for Clinical Excellence (NICE) for Rejecting New Lupus Treatment More...
• Imprimis Pharmaceuticals Closes $7.95 Million Financing and Provides Progress Report to Shareholders More...
• Jazz Pharmaceuticals, Inc. (JAZZ) Buying EUSA Pharma for Up to $700 Million More...
• Renhe Pharmacy Pays $46 Million for Two Pharma Acquisitions More...
• Allenex AB Sells Its Holding in Pharmacolog More...
• VWR International, Inc. Signs Agreement to Acquire basan Germany GmbH More...
• FAES Farma and Invida (a Menarini Group Company) Announce Agreement to Commercialize Bilastine in 17 Markets in Asia - Pacific More...
• Somaxon Pharmaceuticals, Inc. (SOMX) and CJ CheilJedang Announce Silenor® Collaboration in South Korea More...
• Array BioPharma, Inc. (ARRY) Names Ron Squarer Chief Executive Officer More...
• Trinean nv Appoints New CEO and Secures 2.7 Million Euro Financing More...
• PDL BioPharma, Inc. (PDLI) Appoints Bruce Tomlinsonas Chief Financial Officer More...
• Ms. Julia R. Brown and Mr. Davey S. Scoon Join Biodel Inc. (BIOD) Board of Directors More...
• Lota S. Zoth Joins Orexigen Therapeutics, Inc. (OREX) Board of Directors More...
• Alnylam Pharmaceuticals (ALNY) to Webcast Conference Call Discussing First Quarter 2012 Financial Results More...
• Accelrys Inc. (ACCL) to Announce First Quarter 2012 Results on May 3, 2012 More...
• First Quarter 2012/Annual Meeting: BASF With Solid Start to the Year More...
• BioMarin Pharmaceutical Inc. (BMRN) Announces First Quarter 2012 Financial Results More...
• BioScrip (BIOS) to Host First Quarter 2012 Earnings Call More...
• Could Bristol-Myers Squibb Company (BMY) be a Target of Bribery? More...
• Sucampo Pharmaceuticals, Inc. Provides Update on Anticipated Arbitration Decision Date More...
• FDA Rejects Amgen (AMGN)'s BLA for Xgeva More...
• GlaxoSmithKline (GSK) and Genmab A/S (GEN.CO) Release: New Drug Application for Arzerra Submitted in Japan More...
• FDA Warns Not to Mix Merck & Co., Inc. (MRK) Hep C Drug With HIV Meds More...
• FDA Approves Novartis AG (NVS)'s Afinitor for Kidney Tumors More...
• FDA Approves GlaxoSmithKline (GSK)'s Votrient® for Deadly Sarcomas More...
• Results From Chelsea Therapeutics, Inc. (CHTP)' Pivotal Northera (Droxidopa) Study to be Presented at the American Academy of Neurology's Annual Meeting More...
• Baxter International, Inc. (BAX) Presents Efficacy and Safety Data Evaluating GAMMAGARD LIQUID for Multifocal Motor Neuropathy at American Academy of Neurology Annual Meeting More...
• UCB, Inc. (UCBJF.PK) Release: Interim results of VITOBA (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology More...
• New Tysabri Data Presented at 64th Annual American Academy of Neurology Meeting Highlight Biogen Idec, Inc. (Massachusetts) (BIIB) & Biogen Idec, Inc. (Massachusetts) (BIIB) Commitment to Improving Outcomes in Multiple Sclerosis More...
• Building Muscle Without Heavy Weights, McMaster University Study More...
• Analytic Thinking Can Decrease Religious Belief, University of British Columbia Study More...
• Women Who Smoke in Pregnancy More Likely to Have Child With High Functioning Autism, University of Wisconsin Study More...
• High Salt Intake Linked to Higher Stroke Risk, University of Warwick Study More...
• Breast Cancer Link With Diet, Karolinska Institute Study More...
• Ampio Pharmaceuticals, Inc. (AMPE) Awarded US and Canadian Patents That Will Bolster the Commercialization of Optina for the Treatment of Diabetic Macular Edema (DME) More...
• Ranbaxy Laboratories (RANBAXY.BO) Creates India's First New Drug More...
• Pharmaxis Ltd (PXS.AX) Receives Approval to Market Bronchitol in the EU More...
• GlaxoSmithKline (GSK) Attacks National Institute for Clinical Excellence (NICE) for Rejecting New Lupus Treatment More...
• AstraZeneca PLC (AZN) CEO Steps Down More...
• Rempex Pharmaceuticals Appoints Jennifer Cayer New Chief Operating Officer More...
• Albany Molecular Research, Inc. (AMRI) (AMRI) Hires Director of In Vitro Biology in Singapore More...
• BioNeutral Appoints New Board of Directors Member and Seeks to Expand Its Management Team More...
• Valence Life Sciences Announces Promotion of Scott Morenstein and Hiring of Robert Ferraioli More...
• Amgen (AMGN) to Create 100 Jobs More...
• Johnson & Johnson (JNJ) CEO Gorsky Says Company Will Grow While Rivals Shrink More...
• Galena Biopharma (RXII) Takes Final Actions to Complete Spin-Off of RXi Pharmaceuticals (RXII) More...
• Galenea to Receive $6 Million From The Stanley Medical Research Instituteto Progress Pro-Cognitive Drug Discovery and Development Program More...
• Watson Pharmaceuticals, Inc. (WPI)'s $5.9 Billion for Actavis Earning Applause as Shares Pop More...
• Onyx Pharmaceuticals, Inc. (ONXX) Shares Rally Late Afternoon Amid Rumor of Bayer AG (BAY.F) Acquisition More...
• Baxter International, Inc. (BAX) Completes Purchase of SIGMA International More...
• Epizyme Gets $90 Million in Epigenetics Partnership With Celgene Corporation (CELG) More...
• Southern Research Institute Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings More...
• Evotec AG (EVTG.F) and Active Biotech AB (BTPC) Extend and Expand Medicinal Chemistry Collaboration More...
• Zalicus Inc. (ZLCS) Provides Oncology Research Collaboration Update More...
• Hi-Tech Pharmacal (HITK) Licenses Rights to Lidocaine 5% Ointment More...
• Active Biotech AB (BTPC) Interim Report January - March 2012 More...
• AVEO Pharmaceuticals, Inc. (AVEO) Announces Timing for First Quarter Financial Results, Webcast and Conference Call More...
• Alimera Sciences (ALIM) to Release First Quarter Fiscal Year 2012 Financial Results More...
• Acorda Therapeutics (ACOR) to Host Conference Call to Discuss First Quarter 2012 Financial Results on May 3, 2012 More...
• AmerisourceBergen Corporation (ABC) Reports $0.81 in Diluted EPS for the March Quarter More...
• Icahn Drops Suit After Making Nice With Amylin Pharmaceuticals, Inc. (AMLN) CEO More...
• Mylan Inc. (MYL) and Pfizer Inc. (PFE) Announce Epinephrine Auto-injector Settlement Agreement With Teva Pharmaceutical Industries Limited (TEVA) More...
• Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Actos Successor Fails to Win FDA OK More...
• Repligen Corporation (RGEN) Provides Regulatory Update for RG1068 New Drug Application; FDA Cancels Advisory Committee Meeting More...
• Onyx Pharmaceuticals, Inc. (ONXX) Says FDA's ODAC Will Review NDA For Carfilzomib More...
• Pfizer Inc. (PFE) Drug Reduced Autism Signs in Mice More...
• Forest Laboratories, Inc. (FRX) and Pierre Fabre Medicament Announce Third Positive Phase III Study for Levomilnacipran in Patients With Major Depressive Disorder More...
• Shire plc (SHPGY) Reports Positive Phase 2 Study Met Primary End Point for Investigative Use of Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) in Adults With Binge Eating Disorder More...
• Omthera Pharmaceuticals, Inc. Announces Positive Top-Line Results from Phase 3 EVOLVE Study More...
• Banner Sun Health Research Institute Release: Study Findings Confirming Reliable Beta-Amyloid Imaging in the Living Brain Presented at American Academy of Neurology Annual Meeting in New Orleans More...
• Eating More Berries May Delay Memory Decline, Harvard Medical School Study More...
• Poor Sleep Heightens "Ringing Ear" Disease Symptoms, Henry Ford Health System Study More...
• Leafy Greens Help Prevent Damage Caused by a Workout, Edinburgh Napier University Study More...
• Switching Subject Categories Could Improve Test Scores, Syracuse University Study More...
• Feel-Good Music Helps With Psychological Counseling, Concordia University Study More...
• Apricus Biosciences (APRI) Receives Notice of Issuance for First Prevonco Patent in the United States More...
• Bio Scientific Corporation Introduces Optimized Directional RNA-Seq Kits With Innovative Bias Reducing Technology More...
• Tianyin Pharmaceutical Co, Inc. Provides Progress Updates on its GMOL Flagship Product More...
• Watson Pharmaceuticals, Inc. (WPI) and Antares Pharma, Inc. (AIS) Announce the Introduction of Gelnique, for the Treatment of Overactive Bladder More...
• Rempex Pharmaceuticals Appoints Jennifer Cayer New Chief Operating Officer More...
• Albany Molecular Research, Inc. (AMRI) (AMRI) Hires Director of In Vitro Biology in Singapore More...
• BioNeutral Appoints New Board of Directors Member and Seeks to Expand Its Management Team More...
• Valence Life Sciences Announces Promotion of Scott Morenstein and Hiring of Robert Ferraioli More...
• Amgen (AMGN) to Create 100 Jobs More...
• Johnson & Johnson (JNJ) CEO Gorsky Says Company Will Grow While Rivals Shrink More...
• Galena Biopharma (RXII) Takes Final Actions to Complete Spin-Off of RXi Pharmaceuticals (RXII) More...
• Galenea to Receive $6 Million From The Stanley Medical Research Instituteto Progress Pro-Cognitive Drug Discovery and Development Program More...
• Watson Pharmaceuticals, Inc. (WPI)'s $5.9 Billion for Actavis Earning Applause as Shares Pop More...
• Onyx Pharmaceuticals, Inc. (ONXX) Shares Rally Late Afternoon Amid Rumor of Bayer AG (BAY.F) Acquisition More...
• Baxter International, Inc. (BAX) Completes Purchase of SIGMA International More...
• Epizyme Gets $90 Million in Epigenetics Partnership With Celgene Corporation (CELG) More...
• Southern Research Institute Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings More...
• Evotec AG (EVTG.F) and Active Biotech AB (BTPC) Extend and Expand Medicinal Chemistry Collaboration More...
• Zalicus Inc. (ZLCS) Provides Oncology Research Collaboration Update More...
• Hi-Tech Pharmacal (HITK) Licenses Rights to Lidocaine 5% Ointment More...
• Active Biotech AB (BTPC) Interim Report January - March 2012 More...
• AVEO Pharmaceuticals, Inc. (AVEO) Announces Timing for First Quarter Financial Results, Webcast and Conference Call More...
• Alimera Sciences (ALIM) to Release First Quarter Fiscal Year 2012 Financial Results More...
• Acorda Therapeutics (ACOR) to Host Conference Call to Discuss First Quarter 2012 Financial Results on May 3, 2012 More...
• AmerisourceBergen Corporation (ABC) Reports $0.81 in Diluted EPS for the March Quarter More...
• Icahn Drops Suit After Making Nice With Amylin Pharmaceuticals, Inc. (AMLN) CEO More...
• Mylan Inc. (MYL) and Pfizer Inc. (PFE) Announce Epinephrine Auto-injector Settlement Agreement With Teva Pharmaceutical Industries Limited (TEVA) More...
• Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Actos Successor Fails to Win FDA OK More...
• Repligen Corporation (RGEN) Provides Regulatory Update for RG1068 New Drug Application; FDA Cancels Advisory Committee Meeting More...
• Onyx Pharmaceuticals, Inc. (ONXX) Says FDA's ODAC Will Review NDA For Carfilzomib More...
• Pfizer Inc. (PFE) Drug Reduced Autism Signs in Mice More...
• Forest Laboratories, Inc. (FRX) and Pierre Fabre Medicament Announce Third Positive Phase III Study for Levomilnacipran in Patients With Major Depressive Disorder More...
• Shire plc (SHPGY) Reports Positive Phase 2 Study Met Primary End Point for Investigative Use of Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) in Adults With Binge Eating Disorder More...
• Omthera Pharmaceuticals, Inc. Announces Positive Top-Line Results from Phase 3 EVOLVE Study More...
• Banner Sun Health Research Institute Release: Study Findings Confirming Reliable Beta-Amyloid Imaging in the Living Brain Presented at American Academy of Neurology Annual Meeting in New Orleans More...
• Eating More Berries May Delay Memory Decline, Harvard Medical School Study More...
• Poor Sleep Heightens "Ringing Ear" Disease Symptoms, Henry Ford Health System Study More...
• Leafy Greens Help Prevent Damage Caused by a Workout, Edinburgh Napier University Study More...
• Switching Subject Categories Could Improve Test Scores, Syracuse University Study More...
• Feel-Good Music Helps With Psychological Counseling, Concordia University Study More...
• Apricus Biosciences (APRI) Receives Notice of Issuance for First Prevonco Patent in the United States More...
• Bio Scientific Corporation Introduces Optimized Directional RNA-Seq Kits With Innovative Bias Reducing Technology More...
• Tianyin Pharmaceutical Co, Inc. Provides Progress Updates on its GMOL Flagship Product More...
• Watson Pharmaceuticals, Inc. (WPI) and Antares Pharma, Inc. (AIS) Announce the Introduction of Gelnique, for the Treatment of Overactive Bladder More...
In the era of digital payment systems, technology firms are competing to work out an easy electronic approach for payments. Walmart, the giant has work out the way to pay cash while shopping online. Customers who don't have credit cards or bank accounts may find it easier to pay cash of their online purchases at walmart.com
Walmart has set up a system to allow online shoppers to pay with cash. Pay With Cash allows customers without credit cards to choose from Walmart.com's extended catalogue of items, and pay for their purchase at a nearby store. Their order then ships. It's geared towards customers without bank accounts or insufficient electronic banking access--those who "rely on cash transactions, as well as those who are wary of using credit cards online," Walmart explains in a release. Walmart built the system in-house, Walmart.com CEO Joel Anderson told AllThingsD. That's a strategy that online stores employ in other parts of the world like India and China, where a chunk of the population is underbanked, and where customers are still wary of using cards online and prefer to pay for purchases after inspecting them in real life.
Walmart has set up a system to allow online shoppers to pay with cash. Pay With Cash allows customers without credit cards to choose from Walmart.com's extended catalogue of items, and pay for their purchase at a nearby store. Their order then ships. It's geared towards customers without bank accounts or insufficient electronic banking access--those who "rely on cash transactions, as well as those who are wary of using credit cards online," Walmart explains in a release. Walmart built the system in-house, Walmart.com CEO Joel Anderson told AllThingsD. That's a strategy that online stores employ in other parts of the world like India and China, where a chunk of the population is underbanked, and where customers are still wary of using cards online and prefer to pay for purchases after inspecting them in real life.
Below is the list of 50+ Strong Action Verbs You Need to Use on Your Resume Now
By Jessica Holbrook Hernandez, Expert Resume WriterStop using passive terms on your resume; passive terms dilute the quality and value of what you offer the employer. Seriously, if you’re using any of the following terminology, you need to make a change today!
Demonstrated mastery of...Responsibility for...Duties included...Worked with...Familiar with...Knowledge of (or) Knowledgeable in...
These passive terms are not action-oriented, and they make for a rather lackluster resume. Instead, show the employer exactly what you’re capable of achieving and bringing to the table! Below you’ll find a list of 50+ strong action verbs that you can put on your resume NOW to spice things up!
|
Actress of yesteryear Rekha is among four eminent persons who have been recommended for nomination as members of Rajya Sabha.
Rekha, known for her brilliant and emotional portrayals in Hindi cinema in the 80s, will become member of Parliament under a provision of the constitution that allows the President to nominate 12 members to the Upper House.
There is no word from the Government on who the other two are who have been nominated.
Prime Minister Manmohan Singh sent a communication to the Ministry of Home Affairs on Wednesday which has been sent to President Pratibha Patil for notification, sources said.
Article 80 of the Constitution provides for nomination of persons having special knowledge or practical experience in matters such as literature, science, art and social service.
57-year-old Rekha was one of the top heroines of the 80s in Hindi films and and had won several national awards in her acting career.
The House already has a member from the film world in Javed Akhtar, an eminent lyricist and script writer in Hindi cinema.
Rekha, known for her brilliant and emotional portrayals in Hindi cinema in the 80s, will become member of Parliament under a provision of the constitution that allows the President to nominate 12 members to the Upper House.
There is no word from the Government on who the other two are who have been nominated.
Prime Minister Manmohan Singh sent a communication to the Ministry of Home Affairs on Wednesday which has been sent to President Pratibha Patil for notification, sources said.
Article 80 of the Constitution provides for nomination of persons having special knowledge or practical experience in matters such as literature, science, art and social service.
57-year-old Rekha was one of the top heroines of the 80s in Hindi films and and had won several national awards in her acting career.
The House already has a member from the film world in Javed Akhtar, an eminent lyricist and script writer in Hindi cinema.
Datawind, the company that made headlines with the Aakash tablet, has now announced the launch of two new 7-inch low-cost tablets - the Ubislate 7+ and Ubislate 7C with prices starting at Rs 2999 for the 7+. The 7C model will cost Rs 3,999.
Both the tablets come with similar specifications, only that the Ubislate 7C comes with 4GB of internal flash memory compared to 2GB in the Ubislate 7+.
Both the 7-inch tablets are powered by Cortex A8 800 Mhz processor, 256MB RAM and have an 800x480 pixel capacitive touchscreen. Datawind claims that the 3200 mAh battery will deliver upto 180 minutes of usage. The tablets run on Android 2.3 (Gingerbread)
The tablets have microUSB slots for memory expansion and also include an USB port, that can also be used for optional 3G USB modems.
For customers who have pre-booked the Ubilate 7+ from the Datawind website, the shipmets have already started, said the company and will continue for the next few months before retail availability. The Ubislate 7C will be available from end of May.
Both the Datawind Ubislate 7+ and the Ubislate 7C tablets support WiFi and GPRS (SIM and phone functionality).
Both the tablets come with similar specifications, only that the Ubislate 7C comes with 4GB of internal flash memory compared to 2GB in the Ubislate 7+.
Both the 7-inch tablets are powered by Cortex A8 800 Mhz processor, 256MB RAM and have an 800x480 pixel capacitive touchscreen. Datawind claims that the 3200 mAh battery will deliver upto 180 minutes of usage. The tablets run on Android 2.3 (Gingerbread)
The tablets have microUSB slots for memory expansion and also include an USB port, that can also be used for optional 3G USB modems.
For customers who have pre-booked the Ubilate 7+ from the Datawind website, the shipmets have already started, said the company and will continue for the next few months before retail availability. The Ubislate 7C will be available from end of May.
Both the Datawind Ubislate 7+ and the Ubislate 7C tablets support WiFi and GPRS (SIM and phone functionality).
New Delhi: The Congress has recommended cricketer Sachin Tendulkar's name for the Rajya Sabha and is now waiting for Tendulkar to respond to the same, according to sources. Sources say that Sachin Tendulkar may not accept the nomination. However, an official announcement was awaited.
Sources say that the Congress has offered to nominate him in the President's quota. Tendulkar along with his wife Anjali met Congress President Sonia Gandhi at her 10 Janpath Residence in New Delhi.
Although officially the Congress said that Sonia wanted to meet Tendulkar and personally congratulate him on achieving the historic achievement of scoring 100 international centuries, but sources say the main agenda was his nomination for the Rajya Sabha.
Sachin has accepted a nomination for Rajya Sabha, according to the update from sources. He is the first active sportsperson and cricketer to have been nominated to the Rajya Sabha.
Tendulkar along with his wife Anjali met Congress President Sonia Gandhi at her 10 Janpath residence in New Delhi.
Although officially the Congress said that Sonia wanted to meet Tendulkar and personally congratulate him on achieving the historic achievement of scoring 100 international centuries, but sources say the main agenda was his nomination for the Rajya Sabha.
Reacting to the reports of Sachin Tendulkar's proposed nomination, BJP leader Najma Heptulla said, "We are very happy that Tendulkar's name has been proposed for the Rajya Sabha."
"Tendulkar is a great player, we are proud of him. If he is being nominated, surely he would devote some time to Parliament," BJP spokesperson Ravi Shankar Prasad said.
However, the proposal didn't go well with people from the cricket fraternity. Cricket analyst Harsha Bhogle said, "I don't think it is the greatest idea. He doesn't have the experience of governing or doing social work. People are trying to gain mileage out of Tendulkar."
Meanwhile, the Board of Control of Cricket in India (BCCI) welcomed the government's nomination of Tendulkar as a member of the Rajya Sabha, saying that the iconic batsman deserves such an honour.
BCCI Chief Administrative Officer Prof. Ratnakar Shetty said that the Board was happy with the government's move. "We (BCCI) are happy that Tendulkar's services as a sportsperson has been recognised. He's been a true ambassador for the country and he deserves it," he said.
In the past, eminent personalities like directors Shyam Benegal, Mrinal Sen and playback singer Lata Mangeshkar had been the nominated members of the Rajya Sabha.
Sources say that the Congress has offered to nominate him in the President's quota. Tendulkar along with his wife Anjali met Congress President Sonia Gandhi at her 10 Janpath Residence in New Delhi.
Although officially the Congress said that Sonia wanted to meet Tendulkar and personally congratulate him on achieving the historic achievement of scoring 100 international centuries, but sources say the main agenda was his nomination for the Rajya Sabha.
Sachin has accepted a nomination for Rajya Sabha, according to the update from sources. He is the first active sportsperson and cricketer to have been nominated to the Rajya Sabha.
Tendulkar along with his wife Anjali met Congress President Sonia Gandhi at her 10 Janpath residence in New Delhi.
Although officially the Congress said that Sonia wanted to meet Tendulkar and personally congratulate him on achieving the historic achievement of scoring 100 international centuries, but sources say the main agenda was his nomination for the Rajya Sabha.
Reacting to the reports of Sachin Tendulkar's proposed nomination, BJP leader Najma Heptulla said, "We are very happy that Tendulkar's name has been proposed for the Rajya Sabha."
"Tendulkar is a great player, we are proud of him. If he is being nominated, surely he would devote some time to Parliament," BJP spokesperson Ravi Shankar Prasad said.
However, the proposal didn't go well with people from the cricket fraternity. Cricket analyst Harsha Bhogle said, "I don't think it is the greatest idea. He doesn't have the experience of governing or doing social work. People are trying to gain mileage out of Tendulkar."
Meanwhile, the Board of Control of Cricket in India (BCCI) welcomed the government's nomination of Tendulkar as a member of the Rajya Sabha, saying that the iconic batsman deserves such an honour.
BCCI Chief Administrative Officer Prof. Ratnakar Shetty said that the Board was happy with the government's move. "We (BCCI) are happy that Tendulkar's services as a sportsperson has been recognised. He's been a true ambassador for the country and he deserves it," he said.
In the past, eminent personalities like directors Shyam Benegal, Mrinal Sen and playback singer Lata Mangeshkar had been the nominated members of the Rajya Sabha.
O2, one of the biggest U.K. Cell phone networks, has realized that it can seize a place in the digital payment revolution by launching its own system...the O2 Wallet. It's a digital charge card system, which you fill up via payments from a traditional credit card, and then you can transfer funds between £1 and £500 between phones and to the websites of over 100 big-name retailers. For now it can't work in stores, but showing the counter-cultural powers of mobile pay the app lets you scan the barcode of an item you like in a store, and then helps you find it cheaper online. Plus NFC capabilities will be added soon to allow in-store purchases. It's clever, and is a taster of bigger things to come, but it's also a demo of how muddied the mobile payment waters are becoming as every enterprise in the race, from operators to phone makers to credit card firms tries to jockey for best position.
It is not news that BlackBerry is lagging behind as far as their operating system is concerned compared to the likes of Android and iOS who have completely dominated the smartphone sphere in recent years. To amend this situation, BlackBerry announced the BlackBerry 10 OS which would put them in contention as a top smartphone manufacturer. Late last year, former Research in Motion CEO stated that the first device running this upcoming operating system would make its first appearance by the end of 2012. However, for those who are eagerly awaiting the BlackBerry 10 OS, it seems that a report by N4BB has some good news as their sources claim that the first handset using this OS will be unveiled by mid-August 2012. This pushes the release date up quite a bit from what was previously believed.